Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:

Drugs Used in Lower Respiratory Disorders: Overview

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Lymphopenia drives T cell exhaustion in immunodeficient STING gain-of-function mice.

EMBO molecular medicine·2025

Same author

Butyrate receptor HCAR2/GPR109A controls imiquimod-induced psoriasis-like skin inflammation.

Journal of immunology (Baltimore, Md. : 1950)·2025

Same author

Ozone-induced lung injury and inflammation: Pathways and therapeutic targets for pulmonary diseases caused by air pollutants.

Environment international·2025

Same author

Pharmacological inhibition of cathepsin S and of NSPs-AAP-1 (a novel, alternative protease driving the activation of neutrophil serine proteases).

Biochemical pharmacology·2024

Same author

NLRP1 inflammasome promotes senescence and senescence-associated secretory phenotype.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2024

Same author

NLRP6 controls pulmonary inflammation from cigarette smoke in a gut microbiota-dependent manner.

Frontiers in immunology·2023

Same journal

RETRACTED: Bakshi et al. Crocin Inhibits Angiogenesis and Metastasis in Colon Cancer via TNF-α/NF-kB/VEGF Pathways. <i>Cells</i> 2022, <i>11</i>, 1502.

Cells·2026

Same journal

Correction: Verde et al. Molecular Mechanisms of Protein Aggregation in ALS-FTD: Focus on TDP-43 and Cellular Protective Responses. <i>Cells</i> 2025, <i>14</i>, 680.

Cells·2026

Same journal

Inflammation in Cardiomyopathies: Cellular Mechanisms Across Cardiac Phenotype.

Cells·2026

Same journal

IL-4/IL-13-Driven Dysregulation of Epidermal Lipid Metabolism in Atopic Dermatitis: An Immunometabolic Link Between Type 2 Inflammation and Barrier Dysfunction.

Cells·2026

Same journal

Activity of DNA- and RNA-Guided Prokaryotic Argonautes in Human Mitochondria.

Cells·2026

Same journal

Placental Pathophysiology in Maternal Psychoactive Substance Use: Biological, Clinical, and Forensic Perspectives.

Cells·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Aug 22, 2025

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Published on: July 19, 2024

STING Targeting in Lung Diseases.

Dorian de Moura Rodrigues¹, Norinne Lacerda-Queiroz², Isabelle Couillin¹

¹Experimental and Molecular Immunology and Neurogenetics Laboratory, University of Orleans, Centre National de la Recherche Scientifique (CNRS), UMR7355, 45100 Orleans, France.

|November 11, 2022

Summary

This summary is machine-generated.

The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway regulates immunity. Understanding STING activation advances therapies for respiratory diseases, infections, and cancer by developing agonists or antagonists.

Keywords:

STING adjuvant lung vaccine

More Related Videos

Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells

Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells

Published on: May 20, 2020

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Related Experiment Videos

Last Updated: Aug 22, 2025

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Published on: July 19, 2024

Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells

Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells

Published on: May 20, 2020

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Area of Science:

Immunology
Molecular Biology
Respiratory Medicine

Background:

The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is crucial for detecting DNA and initiating immune responses.
STING plays a significant role in innate and adaptive immunity against microbial and host-derived DNA.
Recent research highlights STING's involvement in various respiratory diseases.

Purpose of the Study:

To summarize the biological functions of STING.
To review recent literature on STING's contribution to respiratory diseases.
To discuss the therapeutic potential of modulating STING activation.

Main Methods:

Literature review of STING pathway functions and activation.
Analysis of STING's role in respiratory disease pathogenesis.
Examination of STING agonists and antagonists for therapeutic applications.

Main Results:

STING activation has been increasingly understood, leading to the development of potential therapeutics.
STING antagonists may help manage chronic inflammation and autoimmunity.
STING agonists demonstrate antiviral properties, notably against SARS-CoV-2, and can enhance antitumor responses and vaccine efficacy.

Conclusions:

Modulating the STING pathway offers promising therapeutic strategies for a range of conditions.
Targeting STING can address chronic inflammation, autoimmune disorders, viral infections, and cancer.
Further research into STING modulation is warranted for developing novel treatments.